BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19908906)

  • 1. Multiplexed determination of protein biomarkers using metal-tagged antibodies and size exclusion chromatography--inductively coupled plasma mass spectrometry.
    Terenghi M; Elviri L; Careri M; Mangia A; Lobinski R
    Anal Chem; 2009 Nov; 81(22):9440-8. PubMed ID: 19908906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lanthanide polymer labels for multiplexed determination of biomarkers in human serum samples by means of size exclusion chromatography-inductively coupled plasma mass spectrometry.
    Pérez E; Bierla K; Grindlay G; Szpunar J; Mora J; Lobinski R
    Anal Chim Acta; 2018 Aug; 1018():7-15. PubMed ID: 29605136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly sensitive immunoassay based on immunogold-silver amplification and inductively coupled plasma mass spectrometric detection.
    Liu R; Liu X; Tang Y; Wu L; Hou X; Lv Y
    Anal Chem; 2011 Mar; 83(6):2330-6. PubMed ID: 21348438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of peanut allergens in cereal-chocolate-based snacks: metal-tag inductively coupled plasma mass spectrometry immunoassay versus liquid chromatography/electrospray ionization tandem mass spectrometry.
    Careri M; Elviri L; Maffini M; Mangia A; Mucchino C; Terenghi M
    Rapid Commun Mass Spectrom; 2008; 22(6):807-11. PubMed ID: 18278822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor.
    Ladd J; Lu H; Taylor AD; Goodell V; Disis ML; Jiang S
    Colloids Surf B Biointerfaces; 2009 Apr; 70(1):1-6. PubMed ID: 19157807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
    Jackson D; Craven RA; Hutson RC; Graze I; Lueth P; Tonge RP; Hartley JL; Nickson JA; Rayner SJ; Johnston C; Dieplinger B; Hubalek M; Wilkinson N; Perren TJ; Kehoe S; Hall GD; Daxenbichler G; Dieplinger H; Selby PJ; Banks RE
    Clin Cancer Res; 2007 Dec; 13(24):7370-9. PubMed ID: 18094419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
    Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic markers for early detection of ovarian cancer.
    Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
    Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of multiple proteins on one spot by laser ablation inductively coupled plasma mass spectrometry and application to immuno- microarray with element-tagged antibodies.
    Hu S; Zhang S; Hu Z; Xing Z; Zhang X
    Anal Chem; 2007 Feb; 79(3):923-9. PubMed ID: 17263317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence.
    Havrilesky LJ; Whitehead CM; Rubatt JM; Cheek RL; Groelke J; He Q; Malinowski DP; Fischer TJ; Berchuck A
    Gynecol Oncol; 2008 Sep; 110(3):374-82. PubMed ID: 18584856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CE-based simultaneous liquid-phase noncompetitive enzyme immunoassay for three tumor markers in human serum using electrochemical detection.
    Zhang S; Li X; Zhang F
    Electrophoresis; 2007 Dec; 28(23):4427-34. PubMed ID: 17979157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
    Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
    Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
    Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed immunohistochemical detection of tumor markers in breast cancer tissue using laser ablation inductively coupled plasma mass spectrometry.
    Giesen C; Mairinger T; Khoury L; Waentig L; Jakubowski N; Panne U
    Anal Chem; 2011 Nov; 83(21):8177-83. PubMed ID: 21923169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma.
    Ishikawa M; Yaginuma Y; Hayashi H; Shimizu T; Endo Y; Taniguchi N
    Cancer Res; 1990 Apr; 50(8):2538-42. PubMed ID: 2317833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of serum biomarkers for detection of early stage ovarian cancer.
    Kozak KR; Su F; Whitelegge JP; Faull K; Reddy S; Farias-Eisner R
    Proteomics; 2005 Nov; 5(17):4589-96. PubMed ID: 16237736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioconjugated lanthanide luminescent helicates as multilabels for lab-on-a-chip detection of cancer biomarkers.
    Fernández-Moreira V; Song B; Sivagnanam V; Chauvin AS; Vandevyver CD; Gijs M; Hemmilä I; Lehr HA; Bünzli JC
    Analyst; 2010 Jan; 135(1):42-52. PubMed ID: 20024180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer.
    Nakae M; Iwamoto I; Fujino T; Maehata Y; Togami S; Yoshinaga M; Douchi T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):309-14. PubMed ID: 16764622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.